NICE Bipolar disorder in adolescents – aripiprazole TA292
Aripiprazole (Abilify) is a licensed treatment for moderate to severe manic episodes in young people aged 13+ with bipolar 1 disorder.
Other antipsychotics, such as quetiapine and risperidone, have a similar effectiveness, but have different side-effect profiles.
NICE recommends aripiprazole as a treatment option, so the NHS must make sure it is available for use in line with NICE’s recommendations.
By en:User:Sponge [GFDL (http://www.gnu.org/copyleft/fdl.html) or CC-BY-SA-3.0 (http://creativecommons.org/licenses/by-sa/3.0/)], via Wikimedia Commons